Literature DB >> 2584557

Technetium-99m isonitrile: a perfusion or a viability agent?

J Machac1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2584557     DOI： 10.1016/0735-1097(89)90016-8

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  5 in total

1.  Regional concordance and discordance between rest thallium 201 and sestamibi imaging for assessing tissue viability: comparison with postrevascularization functional recovery.

Authors:  P Marzullo; G Sambuceti; O Parodi; A Gimelli; E Picano; A Giorgetti; A L'Abbate
Journal:  J Nucl Cardiol       Date:  1995 Jul-Aug       Impact factor: 5.952

2.  Resting technetium-99m methoxyisobutylisonitrile cardiac imaging in chronic coronary artery disease: comparison with rest-redistribution thallium-201 scintigraphy.

Authors:  A Cuocolo; S Maurea; L Pace; E Nicolai; A Nappi; M Imbriaco; B Trimarco; M Salvatore
Journal:  Eur J Nucl Med       Date:  1993-12

3.  A new quantitative method for the analysis of cardiac perfusion tomography (SPET): validation in post-infarct patients treated with thrombolytic therapy.

Authors:  L Mortelmans; J Nuyts; I Scheys; F Wackers; E Lesaffre; T Brzostek; M De Roo; H De Geest; P Suetens; A Verbruggen
Journal:  Eur J Nucl Med       Date:  1993-12

4.  Rest-injected thallium-201 redistribution and resting technetium-99m methoxyisobutylisonitrile uptake in coronary artery disease: relation to the severity of coronary artery stenosis.

Authors:  S Maurea; A Cuocolo; L Pace; E Nicolai; A Nappi; M Imbriaco; C Morisco; M Chiariello; B Trimarco; M Salvatore
Journal:  Eur J Nucl Med       Date:  1993-06

5.  A comparison of rest sestamibi and rest-redistribution thallium single photon emission tomography: possible implications for myocardial viability detection in infarcted patients.

Authors:  M Dondi; F Tartagni; F Fallani; S Fanti; M Marengo; I DiTommaso; Q F Zheng; N Monetti
Journal:  Eur J Nucl Med       Date:  1993-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.